Cheryl R. Blanchard
CIK: 0001326530
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Apr 15, 2026XLO
Xilio Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10K shares- - Mar 15, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct25.1K shares- - Mar 15, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct12.1K shares at avg. $14.20$172K - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Award(A)Direct24.5K shares- - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct24.5K shares- - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct14.7K shares at avg. $14.20$209K - Mar 9, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct5.9K shares at avg. $14.96$88K - Mar 9, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct20K shares- - Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
Disposition(D)Direct5K shares- - May 22, 2025VIGL
Vigil Neuroscience, Inc.
Award(A)Direct5K shares- - Mar 17, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct12.2K shares at avg. $15.91$193K - Mar 17, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct25.1K shares- - Mar 14, 2025ANIK
Anika Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
71.4K shares- - Mar 14, 2025ANIK
Anika Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
73.6K shares- - Mar 11, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct30.1K shares- - Mar 11, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct12.7K shares at avg. $16.79$213K - Mar 10, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct20K shares- - Mar 10, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct5.9K shares at avg. $16.62$98K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 15, 2026 |  XLO Xilio Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 10,000 | - | - | Direct |
| Mar 15, 2026 |  ANIK Anika Therapeutics, Inc. | Exercise(M) | 25,131 | - | $0 | Direct |
| Mar 15, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 12,104 | $14.20 | $171,877 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Award(A) | 24,520 | - | $0 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 24,519 | - | $0 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 14,728 | $14.20 | $209,138 | Direct |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 5,871 | $14.96 | $87,830 | Direct |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 20,001 | - | $0 | Direct |
| Aug 5, 2025 |  VIGL Vigil Neuroscience, Inc. | Disposition(D) | 5,000 | - | - | Direct |
| May 22, 2025 | VIGL Vigil Neuroscience, Inc. | Award(A) | 5,000 | - | - | Direct |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 12,152 | $15.91 | $193,338 | Direct |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 25,132 | - | - | Direct |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | Award(A) Restricted Stock Unit | 71,403 | - | - | Direct |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | Award(A) Restricted Stock Unit | 73,559 | - | - | Direct |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 30,060 | - | - | Direct |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 12,675 | $16.79 | $212,813 | Direct |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 20,002 | - | - | Direct |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 5,871 | $16.62 | $97,576 | Direct |
1-18 of 18 transactions
About Blanchard Cheryl R
Blanchard Cheryl R (SEC CIK 0001326530) files insider reports with the SEC as Director of Xilio Therapeutics, Inc. (XLO), Director of Anika Therapeutics, Inc. (ANIK) and Director of Vigil Neuroscience, Inc. (VIGL).
Signal8 holds 9 ownership filings by Blanchard Cheryl R (1 Form 3, 8 Form 4), filed between Mar 11, 2025 and Apr 16, 2026. Those filings report 18 transactions, from Mar 10, 2025 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Blanchard Cheryl R's filings is in WALTHAM, MA.
Recent filings by Blanchard Cheryl R
- Apr 15, 2026: Grant or award of XLO derivative securities (Form 4, code A).
- Mar 15, 2026: Option exercise of ANIK shares (Form 4, code M).
- Mar 15, 2026: Tax withholding of ANIK shares (Form 4, code F).
- Mar 14, 2026: Grant or award of ANIK shares (Form 4, code A).
- Mar 14, 2026: Option exercise of ANIK shares (Form 4, code M).
Other insiders filing for Xilio Therapeutics, Inc. (XLO)
- Houvras Yariv, CHIEF MEDICAL OFFICER
- Bello Akintunde Olatokumbo, Director
- Shannon James Samuel, Director
- Curran Daniel J., Director
- Xu Yuan, Director
- ROSS ROBERT W., Director